Genelux Corp. (GNLX)
2.56
0.00 (0.00%)
USD |
NASDAQ |
Apr 02, 10:56
Genelux Profit Margin (Quarterly) : -115.6K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CorMedix, Inc. | 10.90% |
| Arcutis Biotherapeutics, Inc. | 13.43% |
| MBX Biosciences, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Agenus, Inc. | -31.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -145.9% |
| Return on Assets | -107.2% |
| Return on Invested Capital | -135.3% |
| Gross Profit Margin (Quarterly) | -1.75K% |
| Operating Margin (Quarterly) | -117.6K% |
| Return on Net Operating Assets | -1.00K% |